Cargando…

Prognostic immune-related gene models for breast cancer: a pooled analysis

Breast cancer, the most common cancer among women, is a clinically and biologically heterogeneous disease. Numerous prognostic tools have been proposed, including gene signatures. Unlike proliferation-related prognostic gene signatures, many immune-related gene signatures have emerged as principal b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Jianli, Wang, Ying, Lao, Zengding, Liang, Siting, Hou, Jingyi, Yu, Yunfang, Yao, Herui, You, Na, Chen, Kai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602680/ https://www.ncbi.nlm.nih.gov/pubmed/28979134 http://dx.doi.org/10.2147/OTT.S144015

Ejemplares similares

Impact of body mass index and its change on survival outcomes in patients with early breast cancer: A pooled analysis of individual-level data from BCIRG-001 and BCIRG-005 trials
por: Chen, Haizhu, et al.
Publicado: (2023)

Immune gene patterns and characterization of the tumor immune microenvironment associated with cancer immunotherapy efficacy
por: Lin, Lili, et al.
Publicado: (2023)

Identification of a tumor immune-inflammation signature predicting prognosis and immune status in breast cancer
por: Liu, Yajing, et al.
Publicado: (2023)

Radiomic and clinical data integration using machine learning predict the efficacy of anti-PD-1 antibodies-based combinational treatment in advanced breast cancer: a multicentered study
por: Zhao, Jianli, et al.
Publicado: (2023)

A Prognostic Risk Score Based on Hypoxia-, Immunity-, and Epithelialto-Mesenchymal Transition-Related Genes for the Prognosis and Immunotherapy Response of Lung Adenocarcinoma
por: Ouyang, Wenhao, et al.
Publicado: (2022)

Association of PIK3CA mutation with outcomes in HER2-positive breast cancer treated with anti-HER2 therapy: A meta-analysis and bioinformatic analysis of TCGA‑BRCA data
por: Chen, Haizhu, et al.
Publicado: (2023)

Efficacy and Safety of Cyclin-Dependent Kinases 4 and 6 Inhibitors in HR+/HER2− Advanced Breast Cancer
por: Xie, Ning, et al.
Publicado: (2020)

Multiple metastases of bones and sigmoid colon after mastectomy for ductal carcinoma in situ of the breast: a case report
por: You, Qiuting, et al.
Publicado: (2019)

Association of Immune Checkpoint Inhibitor Therapy With Survival in Patients With Cancers With MUC16 Variants
por: Yu, Yunfang, et al.
Publicado: (2020)

Recognition of Immune Microenvironment Landscape and Immune-Related Prognostic Genes in Breast Cancer
por: Wang, Huiling, et al.
Publicado: (2020)

Development and validation of a nomogram in survival prediction among advanced breast cancer patients
por: Zhao, Jianli, et al.
Publicado: (2020)

Nanoparticles (NPs)-mediated lncBCMA silencing to promote eEF1A1 ubiquitination and suppress breast cancer growth and metastasis
por: Yang, Ke, et al.
Publicado: (2023)

Prognosis and Immunotherapy Response With a Novel Golgi Apparatus Signature-Based Formula in Lung Adenocarcinoma
por: Jiang, Yupeng, et al.
Publicado: (2022)

Effect of prior cancer history on survival of patients with esophageal carcinoma: a propensity score matching, population-based study
por: Liu, Jingwen, et al.
Publicado: (2022)

Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non–Small Cell Lung Cancer: A Meta-analysis and Individual Patient–Level Analysis
por: Yu, Yunfang, et al.
Publicado: (2019)

Association of immune checkpoint inhibitor with survival in patients with cancers with protein tyrosine phosphatase receptor T mutation
por: He, Zifan, et al.
Publicado: (2020)

Development of an immune-related prognostic biomarker for triple-negative breast cancer
por: Zhang, Yan, et al.
Publicado: (2022)

LncRNA Uc003xsl.1-Mediated Activation of the NFκB/IL8 Axis Promotes Progression of Triple-Negative Breast Cancer
por: Xu, Ying, et al.
Publicado: (2022)

Clinical Evidence of Chemotherapy or Endocrine Therapy Maintenance in Patients with Metastatic Breast Cancer: Meta-Analysis of Randomized Clinical Trials and Propensity Score Matching of Multicenter Cohort Study
por: Ren, Wei, et al.
Publicado: (2022)

Development of a Novel Immune-Related Gene Prognostic Index for Breast Cancer
por: Yao, Yan, et al.
Publicado: (2022)

Association of Long Noncoding RNA Biomarkers With Clinical Immune Subtype and Prediction of Immunotherapy Response in Patients With Cancer
por: Yu, Yunfang, et al.
Publicado: (2020)

Prediction of the immunological and prognostic value of five signatures related to fatty acid metabolism in patients with cervical cancer
por: Zeng, Qiongjing, et al.
Publicado: (2022)

Identification of the pyroptosis-related prognostic gene signature and characterization of tumor microenvironment infiltration in triple-negative breast cancer
por: Liu, Ji, et al.
Publicado: (2022)

Magnetic resonance imaging radiomics signatures for predicting endocrine resistance in hormone receptor-positive non-metastatic breast cancer
por: Yang, Yaping, et al.
Publicado: (2021)

An Immune-Related Prognostic Classifier Is Associated with Diffuse Large B Cell Lymphoma Microenvironment
por: Liang, Xiao-Jie, et al.
Publicado: (2021)

Primary breast lymphoma: A pooled analysis of prognostic factors and survival in 93 cases
por: Liu, Mu-tai, et al.
Publicado: (2005)

A Comprehensive Analysis of Programmed Cell Death-Associated Genes for Tumor Microenvironment Evaluation Promotes Precise Immunotherapy in Patients with Lung Adenocarcinoma
por: Huang, Yunxi, et al.
Publicado: (2023)

Joint association of patients’ sex and PD‐L1 expression with overall survival benefits and tumor‐immune microenvironment in immune checkpoint inhibitors for cancers
por: Li, Anlin, et al.
Publicado: (2020)

Prognostic value of immune related genes in lung adenocarcinoma
por: Wang, Han, et al.
Publicado: (2020)

Development of an Immune-Related Prognostic Signature in Breast Cancer
por: Xie, Peiling, et al.
Publicado: (2020)

A novel immune checkpoint-related gene signature for predicting overall survival and immune status in triple-negative breast cancer
por: Liu, Jingyi, et al.
Publicado: (2022)

Comprehensive Analysis of the Glycolysis-Related Gene Prognostic Signature and Immune Infiltration in Endometrial Cancer
por: Yang, Xiao, et al.
Publicado: (2022)

GMFG Has Potential to Be a Novel Prognostic Marker and Related to Immune Infiltrates in Breast Cancer
por: Yang, Yan, et al.
Publicado: (2021)

Global Trend in Research and Development of CDK4/6 Inhibitors for Clinical Cancer Therapy: A Bibliometric Analysis
por: Lai, Hongna, et al.
Publicado: (2021)

Predictive Analyses of Prognostic-Related Immune Genes and Immune Infiltrates for Glioblastoma
por: Liang, Ping, et al.
Publicado: (2020)

Identification and development of an independent immune-related genes prognostic model for breast cancer
por: Chen, Lin, et al.
Publicado: (2021)

Novel immune-related genes in the tumor microenvironment with prognostic value in breast cancer
por: Tan, Wen, et al.
Publicado: (2021)

TIP60-miR-22 axis as a prognostic marker of breast cancer progression
por: Pandey, Amit Kumar, et al.
Publicado: (2015)

Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer
por: Jiang, Ai-Min, et al.
Publicado: (2021)

Development of an Autophagy-Related Gene Prognostic Model and Nomogram for Estimating Renal Clear Cell Carcinoma Survival
por: Wang, Ying, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v9ee5625ud8hbqq2r4fdb9sl1r